Newsletter - October 27, 2022
FDA Provides Guidance of Using Multiple Endpoints in Clinical Trials
A new drug can affect multiple aspects of the disease it is intended to treat, and hence clinical trials are designed to evaluate multiple efficacy endpoints compared to the controls. However, evaluating multiple endpoints in a clinical trial should involve appropriate statistical adjustments to account for the existence...Read More
Critical Deficiency in AI-Enabled Medicine Limit their Practical Application
A key application of digital medical tools is in diagnostic applications that rely on artificial intelligence (AI) algorithms. Experts opine that there are critical deficiencies in the methods used for training and validation of AI tools that might over-estimate the accuracy of these products, and hence make them less reliable. Read More
FDA Provides Guidance of Using Multiple Endpoints in Clinical Trials
A new drug can affect multiple aspects of the disease it is intended to treat, and hence clinical trials are designed to evaluate multiple efficacy endpoints compared to the controls. However, evaluating multiple endpoints in a clinical trial should involve appropriate statistical adjustments to account for the existence...Read More
Critical Deficiency in AI-Enabled Medicine Limit their Practical Application
A key application of digital medical tools is in diagnostic applications that rely on artificial intelligence (AI) algorithms. Experts opine that there are critical deficiencies in the methods used for training and validation of AI tools that might over-estimate the accuracy of these products, and hence make them less reliable. Read More